Summary
The humoral immune response to commercially available bovine collagen implants (Zyderm, Zyplast) is characterized in a 45-year-old female patient. Circulating anti-collagen antibodies were detected after eight injections of Zyderm and after two injections of Zyplast given during a period of 3 years. The specificity of these antibodies for bovine and human collagens as well as for the collagen-like region of C1q (a subcomponent of the first component of complement), was investigated by affinity chromatography. Serum levels of anti-collagen and anti-C1q antibodies were measured using ELISA. High levels of antibodies to bovine collagens, showing a strong cross-reactivity with human collagen type III were detected in the patient's serum. Only weak cross-reactivity with human collagen type I and IV and no reactivity with type II were observed. In addition, these antibodies specifically cross-reacted with the collagen-like region of C1q. The antibody levels decreased continuously and disappeared 1 year after cessation of treatment. These results demonstrate for the first time the formation of autoantibodies upon treatment with a bovine collagen implant. Although antibodies to collagens and C1q have been found in various autoimmune diseases, neither adverse reactions to the bovine collagen implant nor any other clinical symptoms were observed in association with the described antibody response.
Similar content being viewed by others
References
Castrow FF, Krull EA (1983) Injectable collagen implant — update. J Am Acad Dermatol 9:889–895
Charriere G, Hartman DJ, Vignon E, Ronziere MC, Herbage D, Ville G (1988) Antibodies to types I, II, IX and XI collagen in serum of patients with rheumatic diseases. Arthritis Rheum 31:325–332
Charriere G, Bejot M, Schnitzler L, Ville G, Hartmann DJ (1989) Reactions to a bovine collagen implant. Clinical and immunologic study in 705 patients. J Am Acad Dermatol 21:1203–1208
Cooperman L, Micheli D (1984) The immunogenicity of injectable collagen. II. A retrospective review of seventy-two tested and treated patients. J Am Acad Dermatol 120:183–186
DeLustro F, Smith ST, Sundsmo J, Salem G, Kincaid S, Ellingsworth L (1987) Reaction to injectable collagen: Results in animal models and clinical use. Plast Reconstr Surg 79:581–588
DeLustro F, Fries J, Kang A, Katz S, Kaye R, Reichlin M (1988) Immunity to injectable collagen and autoimmune disease: A summary of current understanding. J Dermatol Surg Oncol, 14 [Suppl 1]:57–65
Ellingsworth LR, DeLustro F, Brennan JE, Sawamura S, McPherson J (1986) The human response to reconstituted bovine collagen. J Immunol 136:877–882
Hay FC, Nineham LJ, Roitt IM (1976) Routine assay for the detection of immune complexes of known immunoglobulin class using solid phase C1q. Clin Exp Immunol 24:396–400
Knapp TR, Luck E, Daniels JR (1977) Behaviour of solubilized collagen as a bioimplant. J Surg Res 23:96–105
McCoy JP, Schade WJ, Siegle RJ, Waldinger TP, Vaanderveen EE, Swanson NA (1985) Characterization of the humoral immune response to bovine collagen implants. Arch Dermatol 121:990–994
McCoy JP, Schade W, Siegle RJ, Vanderveen EE, Zachary CB, Waldinger TP, Swanson NA (1987) Immune response to bovine collagen. J Am Acad Dermatol 16:955–960
Meigel WN, Gay S, Weber L (1977) Dermal architecture and collagen type distribution. Arch Dermatol Res 259:1–10
Menzel EJ, Zlabinger GJ, Dunky A, Steffen C (1988) Autoimmunity and T-cell subpopulations in the old age. Arch Gerontol Geriatr 7:249–260
Piez K (1976) Primary structure. In: Ramachandran G, Reddi A (eds) Biochemistry of collagen. Plenum Press, New York, pp 1–25
Reid KBM (1976) Isolation by partial pepsin digestion of the three collagen-like regions present in subcomponent C1q of the first component of human complement. Biochem J 155:5–17
Siegle RJ, McCoy JP, Schade W, Swanson NA (1984) Intradermal implantation of bovine collagen. Arch Dermatol 120:183–187
Terato K, Shimozuru Y, Katayama K, Takemitsu Y, Yamashita I, Miyatsu K, Fujii K, Saagara M, Kobajashi S, Goto M, Nishioka K, Miyasaka N, Nagai Y (1990) Specificity of antibodies to type II collagen in rheumatoid arthritis. Arthritis Rheum 33:1493–1500
Uwatoko S, Mannik M (1989) IgG subclasses of antibodies to the collagen-like region of C1q in patients with systemic lupus erythematosus. Arthritis Rheum 32:1601–1603
Wener MH, Uwatoko S, Mannik M (1989) Antibodies to the collagen-like region of C1q in sera of patients with autoimmune rheumatic diseases. Arthritis Rheum 32:544–551
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Trautinger, F., Kokoschka, E.M. & Menzel, E.J. Antibody formation against human collagen and C1q in response to a bovine collagen implant. Arch Dermatol Res 283, 395–399 (1991). https://doi.org/10.1007/BF00371822
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00371822